Results 101 to 110 of about 1,137,821 (328)

Pulmonary aspergillosis in an immunocompetent patient [PDF]

open access: yesThe Brazilian Journal of Infectious Diseases, 2013
A 59-year-old man with no medical history presented withproductive cough and hemoptysis for two months. Low-grade fever, fatigue and body weight loss were noted.Physical examination disclosed crackles in both lungs andcachectic appearance. Blood examination revealed hypoal-buminemia and generalized inflammation with a highC-reactive protein level. Chest
Chien, Wei-Lun, Tseng, Jeng-Sen
openaire   +6 more sources

Antimicrobial prescribing guidelines for horses in Australia

open access: yesAustralian Veterinary Journal, EarlyView.
The growing problem of antimicrobial resistance also affects equine veterinarians with increasing frequency. Antimicrobial stewardship and responsible prescribing are essential for a future in which effective antimicrobials are available, as it is unlikely that new antimicrobials will become available for use in horses.
L Hardefeldt   +18 more
wiley   +1 more source

Aspergillus nodule, a rare variant of chronic pulmonary aspergillosis mimicking as lung cancer

open access: yesMuller Journal of Medical Sciences and Research, 2020
Chronic pulmonary aspergillosis includes several disease manifestations, including aspergilloma, Aspergillus nodules, chronic cavitary pulmonary aspergillosis, and chronic fibrosing pulmonary aspergillosis.
Manoj Kumar Pandey   +4 more
doaj   +1 more source

Invasive mould infections in the ICU setting: complexities and solutions [PDF]

open access: yes, 2017
Infections caused by filamentous fungi represent a major burden in the ICU. Invasive aspergillosis is emerging in non-neutropenic individuals with predisposing conditions, e.g.
Bassetti, Matteo, Bouza, Emilio
core   +2 more sources

Long‐term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium

open access: yesBritish Journal of Haematology, EarlyView.
The overall survival of patients receiving an allogeneic haematopoietic stem cell transplant (HSCT) for GATA2 deficiency was significantly better if they were transplanted recently, with a bone marrow or cord blood graft and if the transplant was performed before the onset of excess blast. Excess blast before HSCT was the only factor associated with an
Flore Sicre de Fontbrune   +20 more
wiley   +1 more source

Prevalence and fungal profile of pulmonary aspergillosis in immunocompromised and immunocompetent patients of a tertiary care hospital [PDF]

open access: yes, 2014
Background: Aspergillus is a fungus which may present an array of pulmonary manifestations, depending on the patient’s immunological and physiological state. Although the incidence of pulmonary aspergillosis occurs primarily in immunocompromised patients
Prakash Ved, Mishra Prem P, Verma Shashi K, Sinha Shivani, Sharma Mahendra
core   +1 more source

Proven COVID‐19—associated pulmonary aspergillosis in patients with severe respiratory failure

open access: yesMycoses (Berlin), 2021
An increasing number of reports have described the COVID‐19–associated pulmonary aspergillosis (CAPA) as being a further contributing factor to mortality. Based on a recent consensus statement supported by international medical mycology societies, it has
F. Fortarezza   +16 more
semanticscholar   +1 more source

Aspergillosis with pulmonary echinococcosis.

open access: yesCytoJournal, 2006
Pulmonary echinococcal hydatid cysts have been reported coexistent with cryptococcosis and other saprophytic mycosis on histopathological examination of the affected lung tissues. Similar findings have not been reported in FNA samples. The authors describe a similar case diagnosed on fine needle aspiration (FNA) material.
Julie Arora   +4 more
openaire   +3 more sources

Impact of Prior Intravenous Immunoglobulin and Plasmapheresis on Eculizumab or Ravulizumab Treatment for Generalized Myasthenia Gravis: An Analysis of the MG SPOTLIGHT Registry

open access: yesClinical and Experimental Neuroimmunology, EarlyView.
ABSTRACT Objective The complement component 5 inhibitor therapies (C5ITs) eculizumab and ravulizumab are approved for the treatment of generalized myasthenia gravis (gMG). We evaluated the real‐world effectiveness and safety of eculizumab and ravulizumab in patients with gMG with or without prior intravenous immunoglobulin (IVIg) or plasma exchange ...
Akiyuki Uzawa   +2 more
wiley   +1 more source

Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient

open access: yesEmerging Infectious Diseases, 2020
Invasive pulmonary aspergillosis is a complication in critically ill patients with acute respiratory distress syndrome, especially those with severe influenza pneumonia.
Marion Blaize   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy